Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Identification of novel drug-specific PARP inhibitor resistance mechanisms in ovarian cancer–implications for clinical practice | Clinical Feed | MedicHelpline